stockrowArcutis Biotherapeutics, Inc. (ARQT) vs Legend Biotech Corporation Sponsored ADR (LEGN)
- Arcutis Biotherapeutics, Inc. ARQT 25.55 −5.37%
- Legend Biotech Corporation Sponsored ADR LEGN 23.45 +4.04%
Arcutis Biotherapeutics, Inc. and Legend Biotech Corporation Sponsored ADR are both Biotechnology companies. Legend Biotech Corporation Sponsored ADR is the larger, with a market value of $4.4B against $3.4B — 1.3× the size. Legend Biotech Corporation Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Arcutis Biotherapeutics, Inc. trades at 119×. Arcutis Biotherapeutics, Inc. grew revenue faster over the last twelve months: 60.0% against 59.6%. Arcutis Biotherapeutics, Inc. has the higher net margin (5.88% vs −7.20%) and the higher return on invested capital (23.5% vs −9.54%). Across the 17 metrics below, Arcutis Biotherapeutics, Inc. leads on 11 and Legend Biotech Corporation Sponsored ADR on 6.
Valuation
Profitability
| Metric | ARQT | LEGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.18% | 56.58% | 65.16% |
| Operating margin | 6.91% | (5.06%) | 0.00% |
| Net margin | 5.88% | (7.20%) | 0.00% |
| Free cash flow margin | 11.74% | (9.58%) | 0.00% |
| Return on equity | 14.88% | (8.08%) | (50.12%) |
| Return on assets | 6.68% | (5.32%) | (45.60%) |
| Return on invested capital | 23.48% | (9.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack